The V Foundation for Cancer Research Awards 2010 Translational Grants

Nine Translational Grant Recipients Named

The V Foundation for Cancer Research, one of the nation’s leading cancer research fundraising organizations, announced today it has awarded  2010 Translational grants to elite researchers across the United States. Translational grants transform basic scientific discoveries into clinical applications such as new diagnostics and treatments.  The contribution of funding to these research initiatives continuously brings science steps closer to conquering cancer.

Translational research serves as a bridge between the lab bench discoveries and the patient bedside. Information collected at the patient bedside can circle back to the laboratory to fuel additional discoveries. These grants are $600,000, three-year commitments.  This year’s nine recipients range in concentration from lung cancer to breast cancer and metastatic melanoma.

“The V Foundation is proud of the unparalleled passion and work accomplished by these outstanding medical professionals,” said Nick Valvano, CEO of The V Foundation for Cancer Research.  “Our mission for these doctors and researchers is to be able to find a cure for cancer and we hope our funding aids in that process.”

Grants are given to fund all types of cancer through a competitive process strictly supervised by a Scientific Advisory Board comprised of some of the nation’s top doctors and scientists.  Since its inception, The V Foundation has made huge strides, funding over 400 cancer grants nationwide to 92 different institutions. The Foundation has now reached another milestone, having successfully reached $100 million in donations raised to fund cancer research.  The V Foundation awards 100 percent of all direct donations and net proceeds of events directly to cancer research and related programs.

For more information on The V Foundation, please log onto or call 1-800-4JimmyV. You can also visit or to learn more.

About The V Foundation for Cancer Research

The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State basketball coach and ESPN commentator. Since 1993, The Foundation has raised more than $100 million to fund cancer research grants nationwide. It awards 100 percent of all direct cash donations and net proceeds of events directly to cancer research and related programs. The Foundation, which has received seven consecutive top 4-star ratings from Charity Navigator, awards grants through a competitive awards process strictly supervised by a Scientific Advisory Board. For more information on The V Foundation or to make a donation, please visit


Editors Note: A complete list of the 2010 V Foundation Translational grant recipients follows:


V Foundation 2010 Translational Grant Recipients


Mark Alan Rosen, M.D., Ph.D.

William Lee, M.D., Ph.D.

Abramson Cancer Center

University of Pennsylvania

Philadelphia, PA

Use of PET and MR Imaging Biomarkers to Predict Response of Renal Cell Carcinoma to Tyrosine Kinase Inhibitor Therapy


Cory T. Abate-Shen, Ph.D.

Edward Gelmann, M.D.

Herbert Irving Comprehensive Cancer Center

Columbia University

New York, NY

Pre-clinical and clinical appraoches for developing new treatments for castration-resistant prostate cancer


A. Craig Lockhart, M.D.

Siteman Cancer Center

Washington University

St. Louis, MO

Whole genome sequencing to identify predictive markers and novel therapeutic targets in gastric and gastroesophageal cancers


Amir Goldkorn, M.D.

Parkash Gill, M.D.

USC/Norris Comprehensive Cancer Center

Los Angeles, CA

Targeting the Ephrin Pathway:  A Phase 1 Therapeutic Trial with Circulating Tumor Cell Molecular Correlates


Garrett M. Brodeur, M.D.

Robert J. Levy, M.D.

Children’s Hospital of Philadelphia Research Institute

Philadelphia, PA

Nanoparticle Delivery of TRK Inhibitors in Neuroblastomas


Nancy Lin, M.D.

Kornelia Polyak, M.D., Ph.D.

Dana-Farber Cancer Institute

Boston, MA

Targeting the IL-6/JAK2/Stat3 Pathway in Human Breast Cancer

Christopher E. Touloukian, M.D.

Simon Cancer Center

Indiana University

Indianapolis, IN

The Use of Gene-modified Lymphoid Progenitor Cells for Treatment of Patients with Metastatic Melanoma

Funded by The V Foundation Wine Celebration
In Honor of Blakesley and Cyril Chappellet


Derek C. Radisky, Ph.D.

Lynn Hartmann, M.D.

Mayo Clinic Cancer Center

Jacksonville, FL

Lobular Involution and Breast Cancer in Postmenopausal Women


Ignacio I. Wistuba, M.D.

Edward Kim, M.D.

MD Anderson Cancer Center

University of Texas

Houston, TX

The Identification of Biomarkers for Predicting Response to Treatment in Advanced Non-Smal Cell Lung Cancer